Tesamorelin vs Tirzepatide
Overview
Tesamorelin is primarily a performance & growth peptide, while Tirzepatide is used for weight management & metabolic.
This page compares Tesamorelin and Tirzepatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Tesamorelin | Tirzepatide | |
|---|---|---|
| Category | Performance & Growth | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 2 mg | 2.5-15 mg |
| Frequency | daily | weekly |
| Reported benefits | Visceral fat reduction, improved body composition, GH release | Enhanced weight loss, improved insulin sensitivity, better glycemic control, cardiovascular benefits |
| Reported side effects | Joint pain, peripheral edema | Similar to semaglutide: GI disturbances, nausea, potential pancreatitis |
Key differences
Primary use. Tesamorelin is categorised under Performance & Growth, while Tirzepatide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Tesamorelin: FDA-approved. Tirzepatide: FDA-approved.
Dosing. Tesamorelin is typically dosed at 2 mg (daily). Tirzepatide is typically dosed at 2.5-15 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Tesamorelin and Tirzepatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Tesamorelin and Tirzepatide?
- Tesamorelin is primarily a performance & growth peptide, while Tirzepatide is used for weight management & metabolic. Tesamorelin is FDA-approved for one or more indications, whereas Tirzepatide is FDA-approved for one or more indications.
- What is Tesamorelin used for?
- GHRH for visceral fat.
- What is Tirzepatide used for?
- Dual GIP/GLP-1 agonist for weight loss.
- Can you take Tesamorelin and Tirzepatide together?
- Some users combine peptides within a single protocol, but stacking Tesamorelin and Tirzepatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Tesamorelin or Tirzepatide FDA-approved?
- Tesamorelin is FDA-approved for one or more indications. Tirzepatide is FDA-approved for one or more indications.
Read the full articles
- Tesamorelin — full monograph: mechanism, research, dosing & references
- Tirzepatide — full monograph: mechanism, research, dosing & references